Pregnancies in women with Turner's syndrome

被引:102
作者
Hovatta, O [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Obstet & Gynaecol, S-14186 Huddinge, Sweden
关键词
cryopreservation; fertility; hormone replacement therapy; maturation in vitro; oocyte; oocyte donation; ovarian follicle; Turner's syndrome;
D O I
10.3109/07853899708998785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian failure is a typical feature in Turner's syndrome. Therefore, hormone replacement therapy (HRT) is necessary to achieve the development of normal female sexual characteristics and to prevent cardiovascular complications and osteoporosis. Spontaneous puberty occurs in 5-10% of women with Turner's syndrome, and 2-5% of them become pregnant spontaneously. Sexually active young women with Turner's syndrome need contraception. It can be administered as contraceptive pills, which also serve as HRT. Oocyte donation is now a treatment option for infertility of these women. Excellent results have been obtained with 46% of embryo transfers resulting in pregnancy. The pregnancies carry high risks and have to be followed up carefully. The children born following oocyte donation have no additional risks. Risks can be reduced by transferring only one embryo at a time to the uterus, thus avoiding twin pregnancies. Ovarian tissue from young girls with Turner's syndrome could be cryopreserved for infertility treatment in the future, but the optimal age of ovarian biopsy has to be studied, and methods of replantation and maturation of oocytes in vitro have still to be developed. Fertility counselling has become important in the treatment of girls with Turner's syndrome.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 46 条
[1]   A REPORT ON 100 CYCLES OF OOCYTE DONATION - FACTORS AFFECTING THE OUTCOME [J].
ABDALLA, HI ;
BABER, R ;
KIRKLAND, A ;
LEONARD, T ;
POWER, M ;
STUDD, JWW .
HUMAN REPRODUCTION, 1990, 5 (08) :1018-1022
[2]  
Aller V, 1995, CLIN GENET, V48, P317
[3]   Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching [J].
Barnes, FL ;
Crombie, A ;
Gardner, DK ;
Kausche, A ;
LachamKaplan, O ;
Suikkari, AM ;
Tiglias, J ;
Wood, C ;
Trounson, AO .
HUMAN REPRODUCTION, 1995, 10 (12) :3243-3247
[4]  
BAUDIER MM, 1985, OBSTET GYNECOL, V65, pS60
[5]  
Birdsall M, 1996, HUM REPROD, V11, P1587
[6]  
Blumenthal AL, 1997, CLIN GENET, V52, P187
[7]   Maturation in vitro of immature human oocytes for clinical use [J].
Cha, KY ;
Chian, RC .
HUMAN REPRODUCTION UPDATE, 1998, 4 (02) :103-120
[8]   OOCYTE DONATION - THE ROLE OF ENDOMETRIAL RECEPTIVITY [J].
DAVIES, MC ;
ANDERSON, MC ;
MASON, BA ;
JACOBS, HS .
HUMAN REPRODUCTION, 1990, 5 (07) :862-869
[9]   Development in vitro of mouse oocytes from primordial follicles [J].
Eppig, JJ ;
OBrien, MJ .
BIOLOGY OF REPRODUCTION, 1996, 54 (01) :197-207
[10]   Turner's syndrome and pregnancies after oocyte donation [J].
Foudila, T ;
Söderström-Anttila, V ;
Hovatta, O .
HUMAN REPRODUCTION, 1999, 14 (02) :532-535